Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.
Mumm JB, Oft M. Mumm JB, et al. Among authors: oft m. Oncogene. 2008 Oct 6;27(45):5913-9. doi: 10.1038/onc.2008.275. Oncogene. 2008. PMID: 18836472 Review.
IL-10: master switch from tumor-promoting inflammation to antitumor immunity.
Oft M. Oft M. Cancer Immunol Res. 2014 Mar;2(3):194-9. doi: 10.1158/2326-6066.CIR-13-0214. Cancer Immunol Res. 2014. PMID: 24778315 Free article.
Subversion and coercion: the art of redirecting tumor immune surveillance.
Mumm JB, Oft M. Mumm JB, et al. Among authors: oft m. Curr Top Microbiol Immunol. 2011;344:25-39. doi: 10.1007/82_2010_47. Curr Top Microbiol Immunol. 2011. PMID: 20490777 Review.
IL-10 elicits IFNγ-dependent tumor immune surveillance.
Mumm JB, Emmerich J, Zhang X, Chan I, Wu L, Mauze S, Blaisdell S, Basham B, Dai J, Grein J, Sheppard C, Hong K, Cutler C, Turner S, LaFace D, Kleinschek M, Judo M, Ayanoglu G, Langowski J, Gu D, Paporello B, Murphy E, Sriram V, Naravula S, Desai B, Medicherla S, Seghezzi W, McClanahan T, Cannon-Carlson S, Beebe AM, Oft M. Mumm JB, et al. Among authors: oft m. Cancer Cell. 2011 Dec 13;20(6):781-96. doi: 10.1016/j.ccr.2011.11.003. Cancer Cell. 2011. PMID: 22172723
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs.
Emmerich J, Mumm JB, Chan IH, LaFace D, Truong H, McClanahan T, Gorman DM, Oft M. Emmerich J, et al. Among authors: oft m. Cancer Res. 2012 Jul 15;72(14):3570-81. doi: 10.1158/0008-5472.CAN-12-0721. Epub 2012 May 11. Cancer Res. 2012. PMID: 22581824
IL-23 promotes tumour incidence and growth.
Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M. Langowski JL, et al. Among authors: oft m. Nature. 2006 Jul 27;442(7101):461-5. doi: 10.1038/nature04808. Epub 2006 May 10. Nature. 2006. PMID: 16688182
Swords into plowshares: IL-23 repurposes tumor immune surveillance.
Langowski JL, Kastelein RA, Oft M. Langowski JL, et al. Among authors: oft m. Trends Immunol. 2007 May;28(5):207-12. doi: 10.1016/ Epub 2007 Mar 28. Trends Immunol. 2007. PMID: 17395538
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.
Naing A, Papadopoulos KP, Autio KA, Ott PA, Patel MR, Wong DJ, Falchook GS, Pant S, Whiteside M, Rasco DR, Mumm JB, Chan IH, Bendell JC, Bauer TM, Colen RR, Hong DS, Van Vlasselaer P, Tannir NM, Oft M, Infante JR. Naing A, et al. Among authors: oft m. J Clin Oncol. 2016 Oct 10;34(29):3562-3569. doi: 10.1200/JCO.2016.68.1106. J Clin Oncol. 2016. PMID: 27528724 Free PMC article. Clinical Trial.
Metastasis is driven by sequential elevation of H-ras and Smad2 levels.
Oft M, Akhurst RJ, Balmain A. Oft M, et al. Nat Cell Biol. 2002 Jul;4(7):487-94. doi: 10.1038/ncb807. Nat Cell Biol. 2002. PMID: 12105419
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.
Teng MW, Andrews DM, McLaughlin N, von Scheidt B, Ngiow SF, Möller A, Hill GR, Iwakura Y, Oft M, Smyth MJ. Teng MW, et al. Among authors: oft m. Proc Natl Acad Sci U S A. 2010 May 4;107(18):8328-33. doi: 10.1073/pnas.1003251107. Epub 2010 Apr 19. Proc Natl Acad Sci U S A. 2010. PMID: 20404142 Free PMC article.
36 results
Jump to page